Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma-Reference-Cited by-同舟云学术

Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma

Published:2022-01-18 Issue:2 Volume:132 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Kristensen Nikolaj Pagh^ORCID,Heeke Christina,Tvingsholm Siri A.,Borch Annie^ORCID,Draghi Arianna,Crowther Michael D.,Carri Ibel^ORCID,Munk Kamilla K.^ORCID,Holm Jeppe Sejerø,Bjerregaard Anne-Mette^ORCID,Bentzen Amalie Kai^ORCID,Marquard Andrea M.,Szallasi Zoltan^ORCID,McGranahan Nicholas^ORCID,Andersen Rikke^ORCID,Nielsen Morten^ORCID,Jönsson Göran B.^ORCID,Donia Marco,Svane Inge Marie,Hadrup Sine Reker

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/150535/files/pdf

Reference66 articles.

1. Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

2. Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies

3. Establishment and Large-scale Expansion of Minimally cultured “Young” Tumor Infiltrating Lymphocytes for Adoptive Transfer Therapy

4. Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen

5. In situ click chemistry generation of cyclooxygenase-2 inhibitors

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in tumor-infiltrating lymphocytes: Historical insights, contemporary milestones, and future directions in oncology therapy;Critical Reviews in Oncology/Hematology;2024-10

2. Enhancing pancreatic cancer immunotherapy: Leveraging localized delivery strategies through the use of implantable devices and scaffolds;Journal of Controlled Release;2024-09

3. Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma;Immunity;2024-09

4. Advancements and Challenges in Cancer Immunotherapy;Advances in Medical Diagnosis, Treatment, and Care;2024-08-28

5. Current status and perspectives of clinical trials for tumor-infiltrating lymphocyte therapy;Clinical and Translational Oncology;2024-07-30